CD8A and neoplasm: Multiparameter flow cytometry analysis of myeloid and lymphoid cells in tumors confirmed a high percentage of CD4+ and CD8+ T cells in the tumor tissue obtained from mice treated with DC/IL-18 + IL-12/TAg, 7 days after the administration of vaccines.